1. Agency for Healthcare Research and Quality. Diagnosis and treatment of Parkinson’s disease: a systematic review of the literature. Summary. Evidence Report/Technology Assessment No. 57; 2003.
2. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-22.
3. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 2001;16:507-10.
4. Nutt JG, Wooten GF. Diagnosis and initial management of Parkinson’s disease. N Engl J Med 2005;353:1021-7.
5. Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet 2004;363:1783-93.
6. Young R. Update on Parkinson’s disease. Am Fam Physician 1999;59:2155-68.
7. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Neurology 2006;66:968-75.
8. Miyasaki JM, Shannon K, Voon V, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Neurology 2006;66:996-1002.
9. Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Neurology 2006;66:976-82.
10. Olanow CW, Stocchi F. COMT inhibitors in Parkinson’s disease. Neurology 2004;62:S72-S81.
11. Dickerson LM, Young SE, Simpson WM, Nashelsky J. FPIN’s Clinical Inquiries. Treatment of early Parkinson’s disease. Am Fam Physician 2005;72:497-9.
12. Ahlskog JE. Parkinson’s disease: is the initial treatment established? Curr Neurol Neurosci Rep 2003;3:289-95.
13. Siderowf A, Stern M. Update on Parkinson disease. Ann Intern Med 2003;138:651-8.
14. Rascol O, Brooks DJ, Melamed E, et al. Rasagiline as an adjunct to levodopa in patients with Parkinson’s disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Lancet 2005;365:947-54.
15. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006;355:896-908.
16. Leroi I, Brandt J, Reich S, et al. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson’s disease. Int J of Geriatr Psychiatry 2004;19:1-8.
17. Cleveland Clinic Health System. Orthostatic hypotension and Parkinson’s disease. May 8, 2001. Retrieved from the World Wide Web on September 30, 2006: http://www.cchs.net/health/health-info/docs/2300/2319.asp?index=9385.
